Primary Record
bicalutamide
- In stock
- 1,696 g
- Purity
- 99.3 %
- CAS
- 90357-06-5
Compound Identifiers & Properties
- CAS
- 90357-06-5
- PubChem CID
- 2375
- SMILES
- CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
- Canonical SMILES
- CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1
Names & Synonyms
- bicalutamide
- Casodex
- 90357-06-5
- Cosudex
- Calutide
- Kalumid
- bicalutamida
- Raffolutil
- Bicalutamide (CDX)
- bicalutamidum
- (R)-Bicalutamide
- (S)-Bicalutamide
- Bicalutamine
- Propanamide
- Propanamide,
- Bicalutamide RS
- Bicalutamide-d4
- Calutide;
- Casodex;
- Cosudex;
- Bicalutamide CRS
- Casodex (TN)
- Calutide (TN)
- Cosudex (TN)
- Kalumid (TN)
- (S)-Bicalutamide-d4
- C18H14F4N2O4S
- A0Z3NAU9DP
- Bicalutamide(Casodex)
- ICI 176334
- (R)-Bicalutamide-d4
- UNII-A0Z3NAU9DP
- Bicalutamide (Casodex)
- Bicalutamide - Casodex
- ICI-176334
- Bicalutamide (Standard)
- CHEMBL409
- RefChem:54538
- AC1L1DJE
- BICALUTAMIDE [MI]
- Bicalutamide [USAN:INN:BAN]
- BICALUTAMIDE [INN]
- BICALUTAMIDE [JAN]
- DTXSID2022678
- MFCD00869971
- D0V9BD
- Astra brand of bicalutamide
- BICALUTAMIDE [HSDB]
- BICALUTAMIDE [USAN]
- BicalutamideICI-176334
- SCHEMBL3611
- CCRIS 8728
- LKJPYSCBVHEWIU-UHFFFAOYSA-N
- Zeneca brand of bicalutamide
- BICALUTAMIDE [VANDF]
- BICALUTAMIDE [MART.]
- ICI 176,334
- HSDB 7655
- MLS000759437
- MLS001424047
- BICALUTAMIDE [USP-RS]
- BICALUTAMIDE [WHO-DD]
- NSC-759816
- Bicalutamide (JAN/USP/INN)
- DTXCID00209197
- Bicalutamide [USAN:BAN:INN]
- CHEBI:3090
- GTPL2863
- orb1310668
- PRO113
- SCHEMBL29353850
- AstraZeneca brand of bicalutamide
- BDBM18525
- Bicalutamide (JP18/USP/INN)
- Bicalutamide [USAN:USP:INN:BAN]
- Bicalutamide Crystalline Form II
- Bicalutamide, 99% - 1G 1g
- CHEBI:91617
- KS-00000XEI
- AOB5596
- BRN 5364666
- CID2375
- EX-A962
- L02BB03
- CHEBI:144093
- NSC722665
- BCPP000337
- BICALUTAMIDE [ORANGE BOOK]
- Bicalutamide for system suitability
- GLXC-06685
- HMS2051B13
- HMS2089N12
- HMS2232H03
- HMS3263M13
- HMS3372K05
- HMS3393B13
- HMS3654K18
- HMS3714P13
- HMS5079I13
- ICI176,334-1
- Pharmakon1600-01504827
- BICALUTAMIDE [EP MONOGRAPH]
- BICALUTAMIDE [USP IMPURITY]
- N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methylpropanamide
- ACT06291
- AMY33430
- BCP02110
- CID:2375
- KS-1161
- MSK11156
- SYB76979
- BICALUTAMIDE [USP MONOGRAPH]
- Tox21_112488
- Tox21_303560
- Tox21_501026
- AN-582
- CB0180
- EBC-00668
- HY-14249R
- NSC759816
- s1190
- CPD000466329
- AKOS015895073
- AC-4232
- AT-9158
- BCP9000408
- Bicalutamide for system suitability CRS
- CCG-100951
- CCG-220876
- CCG-222330
- CS-1296
- CS-O-01015
- DB01128
- IC58278
- LP01026
- NC00201
- NSC 759816
- NSC-722665
- SB17301
- SDCCGSBI-0633779.P001
- C18-H14-F4-N2-O4-S
- N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide
- NCGC00167487-01
- NCGC00167977-01
- NCGC00167977-02
- NCGC00167977-03
- NCGC00167977-09
- NCGC00167977-20
- NCGC00257459-01
- NCGC00261711-01
- AK544272
- BC204097
- HY-14249
- SAM001246612
- SC-17332
- SID:53790604
- SMR000466329
- SY057461
- AB0008136
- CAS-90357-06-5
- DB-041165
- J636.420I
- LS-119125
- TL8005814
- A5065
- B3206
- FT-0618286
- FT-0631069
- FT-0663100
- NS00000400
- SW197581-4
- Bicalutamide (CDX), >=98% (HPLC), powder
- C08160
- D00961
- J10442
- AB00639963-06
- AB00639963-08
- AB00639963-09
- AB00639963_10
- EN300-1715981
- 357B065
- A843528
- C053541
- Casodex, Cosudex, Calutide, Kalumid, Bicalutamide
- SR-01000759410
- 113299-40-4
- I06-0475
- I06-0480
- Q1988832
- SR-01000759410-4
- SR-01000759410-5
- (+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide
- BRD-A29485665-001-03-7
- BRD-A29485665-001-11-0
- BRD-A29485665-001-12-8
- N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
- Propanamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methyl-, (+-)-
- Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-
- Z2108698963
- 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide
- Bicalutamide, British Pharmacopoeia (BP) Reference Standard
- 113299-38-0
- Bicalutamide, European Pharmacopoeia (EP) Reference Standard
- 4-cyano-3-trifluoromethyl-N-(3-p-fluorophenylsulfonyl-2-hydroxy-2-methylpropionyl)aniline
- Bicalutamide, United States Pharmacopeia (USP) Reference Standard
- 1217769-79-3
- N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorobenzenesulfonyl)-2-hydroxy-2-methylpropanamide
- N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamide
- 4'-cyano-3-[(4- fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3'-trifluoromethylpropionanilide
- 4'-cyano-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3'-trifluoromethylpropionanilide
- 4'-Cyano-alpha,alpha,alpha-trifuloro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide
- Bicalutamide for system suitability, European Pharmacopoeia (EP) Reference Standard
- Bicalutamide, Pharmaceutical Secondary Standard; Certified Reference Material
- N-[3-(Trifluoromethyl)-4-cyanophenyl]-2-hydroxy-3-(4-fluorophenylsulfonyl)isobutyramide
- (+-)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methylpropanamide
- (+/-)-4'-CYANO-.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-3-((P-FLUOROPHENYL)SULFONYL)-2-METHYL-M-LACTOTOLUIDIDE
- (2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide
- (2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamidenone
- (2R)-N-[4-CYANO-3-(TRIFLUOROMETHYL)PHENYL]-3-[(4-FLUOROPHENYL)SULFONYL]-2-HYDROXY-2-METHYLPROPANAMIDE
- (2S)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide
- 1185035-71-5
- 1217826-87-3
- N-(3-Trifluoromethyl-4-cyanophenyl)-2-methyl-2-hydroxy-3-[(4-fluorophenyl)sulfonyl]propionamide
- N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-fluorobenzenesulfonyl)-2-hydroxy-2-methylpropanamide
- N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide
- N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide
- N-(4-Cyano-3-(trifluoromethyl)phenyl)3-3((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methyl-propanamide
- N-[(4-CYANO-3-TRIFLUOROMETHYL)PHENYL]-3-[(4-FLUOROPHENYL)SULFONYL]-2-HYDROXY-2-METHYLPROPANAMIDE
- N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorobenzene-1-sulfonyl)-2-hydroxy-2-methylpropanamide
- N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide
- N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorobenzene)sulfonyl]-2-hydroxy-2-methylpropanamide
- N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfinyl]-2-hydroxy-2-methylpropanamide
- N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide; Bicalutamide; Casodex; Cosudex; ICI 176334; ZD 176334; (+/-)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide; (+/-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-[(p-fluorophenyl)sulfonyl]-2-methyl-m-lactotoluidide
- N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropionamide
- N-[4-cyano-3-trifluoromethyl-phenyl]-3-[4-fluorophenyl-sulfonyl]-2-hydroxy-2-methyl-propionamide
- Propanamida, N-[4-ciano-3-(trifluorometil)] fenil-3-[(4-fluorofenil) sulfonil]-2-hidroxi-2-metil-
- PROPANAMIDE, N-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)-3-((4-FLUOROPHENYL)SULFONYL)-2-HYDROXY-2-METHYL-, (+/-)-
- propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-,(+-)